{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:24:46Z","timestamp":1790645086867,"version":"4.1.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T00:00:00Z","timestamp":1523318400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13023-018-0793-7","type":"journal-article","created":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T11:13:33Z","timestamp":1524136413000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Epidermal necrolysis French national diagnosis and care protocol (PNDS; protocole national de diagnostic et de soins)"],"prefix":"10.1186","volume":"13","author":[{"name":"the French National Reference Center for Toxic Bullous Dermatoses","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saskia","family":"Ingen-Housz-Oro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tu-Anh","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Bensaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalia","family":"Bellon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"de Prost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9vy","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Lebrun-Vignes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Gueudry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Bequignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Zaghbib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Royer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Colin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giao","family":"Do-Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bodemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Ortonne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annick","family":"Barbaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Fardet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Chosidow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Wolkenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,10]]},"reference":[{"key":"793_CR1","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1016\/S0140-6736(16)30378-6","volume":"390","author":"TA Duong","year":"2017","unstructured":"Duong TA, Valeyrie-Allanore L, Wolkenstein P, Chosidow O. Severe cutaneous adverse reactions to drugs. Lancet. 2017;390:1996\u20132011.","journal-title":"Lancet"},{"key":"793_CR2","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1038\/jid.2012.510","volume":"133","author":"P Sekula","year":"2013","unstructured":"Sekula P, Dunant A, Mockenhaupt M, Naldi L, Bouwes Bavinck JN, Halevy S, et al. Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. J Invest Dermatol. 2013;133:1197\u2013204.","journal-title":"J Invest Dermatol"},{"key":"793_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/clpt.2009.252","volume":"88","author":"B Sassolas","year":"2010","unstructured":"Sassolas B, Haddad C, Mockenhaupt M, Dunant A, Liss Y, Bork K, et al. ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: comparison with case-control analysis. Clin Pharmacol Ther. 2010;88:60\u20138.","journal-title":"Clin Pharmacol Ther"},{"key":"793_CR4","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1750-1172-5-39","volume":"5","author":"T Harr","year":"2010","unstructured":"Harr T, French LE. Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet J Rare Dis. 2010;5:39.","journal-title":"Orphanet J Rare Dis"},{"key":"793_CR5","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2340\/00015555-2295","volume":"96","author":"C-W Yang","year":"2016","unstructured":"Yang C-W, Cho Y-T, Chen K-L, Chen Y-C, Song H-L, Chu C-Y. Long-term sequelae of Stevens-Johnson syndrome\/toxic epidermal necrolysis. Acta Derm Venereol. 2016;96:525\u20139.","journal-title":"Acta Derm Venereol"},{"key":"793_CR6","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1001\/archderm.136.3.323","volume":"136","author":"I Garcia-Doval","year":"2000","unstructured":"Garcia-Doval I, LeCleach L, Bocquet H, Otero XL, Roujeau JC. Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death? Arch Dermatol. 2000;136:323\u20137.","journal-title":"Arch Dermatol"},{"key":"793_CR7","doi-asserted-by":"publisher","first-page":"S276","DOI":"10.1016\/j.annder.2014.09.120","volume":"141","author":"L Valeyrie-Allanore","year":"2014","unstructured":"Valeyrie-Allanore L, Katsahyan S, Tu-Anh D, De Prost N, Sbidian E, Zehou O, et al. Mortalit\u00e9 du SJS-NET et impact de la ciclosporine : \u00e9tude r\u00e9trospective de 130 patients. Ann Dermatol V\u00e9n\u00e9r\u00e9ologie. 2014;141:S276\u20137.","journal-title":"Ann Dermatol V\u00e9n\u00e9r\u00e9ologie"},{"key":"793_CR8","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/bjd.12488","volume":"169","author":"J Chanal","year":"2013","unstructured":"Chanal J, Ingen-Housz-Oro S, Ortonne N, Duong T-A, Thomas M, Valeyrie-Allanore L, et al. Linear IgA bullous dermatosis: comparison between drug-induced and spontaneous forms. Br J Dermatol. 2013;169:1041\u20138.","journal-title":"Br J Dermatol"},{"key":"793_CR9","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1016\/j.jaad.2011.10.007","volume":"68","author":"L Valeyrie-Allanore","year":"2013","unstructured":"Valeyrie-Allanore L, Bastuji-Garin S, Gu\u00e9gan S, Ortonne N, Bagot M, Roujeau J-C, et al. Prognostic value of histologic features of toxic epidermal necrolysis. J Am Acad Dermatol. 2013;68:e29\u201335.","journal-title":"J Am Acad Dermatol"},{"key":"793_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/sj.jid.5701033","volume":"128","author":"M Mockenhaupt","year":"2008","unstructured":"Mockenhaupt M, Viboud C, Dunant A, Naldi L, Halevy S, Bouwes Bavinck JN, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study. J Invest Dermatol. 2008;128:35\u201344.","journal-title":"J Invest Dermatol"},{"key":"793_CR11","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.revmed.2014.10.004","volume":"36","author":"B Lebrun-Vignes","year":"2015","unstructured":"Lebrun-Vignes B, Valeyrie-Allanore L. Cutaneous adverse drug reactions. Rev Med Interne. 2015;36:256\u201370.","journal-title":"Rev Med Interne"},{"key":"793_CR12","doi-asserted-by":"publisher","first-page":"525","DOI":"10.2332\/allergolint.11-OA-0309","volume":"60","author":"Y Kunimi","year":"2011","unstructured":"Kunimi Y, Hirata Y, Aihara M, Yamane Y, Ikezawa Z. Statistical analysis of Stevens-Johnson syndrome caused by mycoplasma pneumonia infection in Japan. Allergol Int. 2011;60:525\u201332.","journal-title":"Allergol Int"},{"key":"793_CR13","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/pde.13140","volume":"34","author":"A Mayor-Ibarguren","year":"2017","unstructured":"Mayor-Ibarguren A, Feito-Rodriguez M, Gonz\u00e1lez-Ramos J, Del Rosal-Rabes T, Gonz\u00e1lez-Sainz FJ, S\u00e1nchez-Orta A, et al. Mucositis secondary to chlamydia pneumoniae infection: expanding the mycoplasma pneumoniae-induced rash and mucositis concept. Pediatr Dermatol. 2017;34:465\u201372.","journal-title":"Pediatr Dermatol"},{"key":"793_CR14","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1191\/0961203304lu2037sa","volume":"13","author":"W Ting","year":"2004","unstructured":"Ting W, Stone MS, Racila D, Scofield RH, Sontheimer RD. Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus and the spectrum of the acute syndrome of apoptotic pan-epidermolysis (ASAP): a case report, concept review and proposal for new classification of lupus erythematosus vesiculobullous skin lesions. Lupus. 2004;13:941\u201350.","journal-title":"Lupus"},{"key":"793_CR15","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/bjd.12133","volume":"168","author":"S Lipowicz","year":"2013","unstructured":"Lipowicz S, Sekula P, Ingen-Housz-Oro S, Liss Y, Sassolas B, Dunant A, et al. Prognosis of generalized bullous fixed drug eruption: comparison with Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol. 2013;168:726\u201332.","journal-title":"Br J Dermatol"},{"key":"793_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1034\/j.1600-0560.2001.028003113.x","volume":"28","author":"A Sidoroff","year":"2001","unstructured":"Sidoroff A, Halevy S, Bavinck JN, Vaillant L, Roujeau JC. Acute generalized exanthematous pustulosis (AGEP)--a clinical reaction pattern. J Cutan Pathol. 2001;28:113\u20139.","journal-title":"J Cutan Pathol"},{"key":"793_CR17","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","volume":"156","author":"SH Kardaun","year":"2007","unstructured":"Kardaun SH, Sidoroff A, Valeyrie-Allanore L, Halevy S, Davidovici BB, Mockenhaupt M, et al. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol. 2007;156:609\u201311.","journal-title":"Br J Dermatol"},{"key":"793_CR18","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1750-1172-7-72","volume":"7","author":"S Bouvresse","year":"2012","unstructured":"Bouvresse S, Valeyrie-Allanore L, Ortonne N, Konstantinou MP, Kardaun SH, Bagot M, et al. Toxic epidermal necrolysis, DRESS, AGEP: do overlap cases exist? Orphanet J Rare Dis. 2012;7:72.","journal-title":"Orphanet J Rare Dis"},{"key":"793_CR19","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1001\/archderm.138.8.1019","volume":"138","author":"A Auquier-Dunant","year":"2002","unstructured":"Auquier-Dunant A, Mockenhaupt M, Naldi L, Correia O, Schr\u00f6der W, Roujeau J-C, et al. Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study. Arch Dermatol. 2002;138:1019\u201324.","journal-title":"Arch Dermatol"},{"key":"793_CR20","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jaad.2014.06.026","volume":"72","author":"TN Canavan","year":"2015","unstructured":"Canavan TN, Mathes EF, Frieden I, Shinkai K. Mycoplasma pneumoniae-induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme: a systematic review. J Am Acad Dermatol. 2015;72:239\u201345.","journal-title":"J Am Acad Dermatol"},{"key":"793_CR21","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/00004630-200021030-00004","volume":"21","author":"JT Schulz","year":"2000","unstructured":"Schulz JT, Sheridan RL, Ryan CM, MacKool B, Tompkins RG. A 10-year experience with toxic epidermal necrolysis. J Burn Care Rehabil. 2000;21:199\u2013204.","journal-title":"J Burn Care Rehabil"},{"key":"793_CR22","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/CCM.0b013e31829eb94f","volume":"42","author":"N de Prost","year":"2014","unstructured":"de Prost N, Mekontso-Dessap A, Valeyrie-Allanore L, Van Nhieu JT, Duong T-A, Chosidow O, et al. Acute respiratory failure in patients with toxic epidermal necrolysis: clinical features and factors associated with mechanical ventilation. Crit Care Med. 2014;42:118\u201328.","journal-title":"Crit Care Med"},{"key":"793_CR23","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1097\/01.PRS.0000019761.69444.10","volume":"110","author":"I Ducic","year":"2002","unstructured":"Ducic I, Shalom A, Rising W, Nagamoto K, Munster AM. Outcome of patients with toxic epidermal necrolysis syndrome revisited. Plast Reconstr Surg. 2002;110:768\u201373.","journal-title":"Plast Reconstr Surg"},{"key":"793_CR24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","volume":"115","author":"S Bastuji-Garin","year":"2000","unstructured":"Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, Wolkenstein P. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol. 2000;115:149\u201353.","journal-title":"J Invest Dermatol"},{"key":"793_CR25","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/sj.jid.5700068","volume":"126","author":"S Gu\u00e9gan","year":"2006","unstructured":"Gu\u00e9gan S, Bastuji-Garin S, Poszepczynska-Guign\u00e9 E, Roujeau J-C, Revuz J. Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis. J Invest Dermatol. 2006;126:272\u20136.","journal-title":"J Invest Dermatol"},{"key":"793_CR26","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1111\/bjd.14530","volume":"174","author":"D Creamer","year":"2016","unstructured":"Creamer D, Walsh SA, Dziewulski P, Exton LS, Lee HY, Dart JKG, et al. U.K. guidelines for the management of Stevens-Johnson syndrome\/toxic epidermal necrolysis in adults 2016. Br J Dermatol. 2016;174:1194\u2013227.","journal-title":"Br J Dermatol"},{"key":"793_CR27","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1097\/BCR.0b013e3181848bb1","volume":"29","author":"FW Endorf","year":"2008","unstructured":"Endorf FW, Cancio LC, Gibran NS. Toxic epidermal necrolysis clinical guidelines. J Burn Care Res. 2008;29:706\u201312.","journal-title":"J Burn Care Res"},{"key":"793_CR28","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/00005792-200211000-00007","volume":"81","author":"N Safdar","year":"2002","unstructured":"Safdar N, Kluger DM, Maki DG. A review of risk factors for catheter-related bloodstream infection caused by percutaneously inserted, noncuffed central venous catheters: implications for preventive strategies. Medicine. 2002;81:466\u201379.","journal-title":"Medicine"},{"key":"793_CR29","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/MD.0b013e3181ca4290","volume":"89","author":"N de Prost","year":"2010","unstructured":"de Prost N, Ingen-Housz-Oro S, Duong TA, Valeyrie-Allanore L, Legrand P, Wolkenstein P, et al. Bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: epidemiology, risk factors, and predictive value of skin cultures. Medicine. 2010;89:28\u201336.","journal-title":"Medicine"},{"key":"793_CR30","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1001\/jama.281.3.261","volume":"281","author":"DL Veenstra","year":"1999","unstructured":"Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA. 1999;281:261\u20137.","journal-title":"JAMA"},{"key":"793_CR31","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/BCR.0b013e31815f3876","volume":"29","author":"TN Pham","year":"2008","unstructured":"Pham TN, Cancio LC, Gibran NS, American Burn Association. American burn association practice guidelines burn shock resuscitation. J Burn Care Res. 2008;29:257\u201366.","journal-title":"J Burn Care Res"},{"key":"793_CR32","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/00005373-197101000-00003","volume":"11","author":"BA Pruitt","year":"1971","unstructured":"Pruitt BA, Mason AD, Moncrief JA. Hemodynamic changes in the early postburn patient: the influence of fluid administration and of a vasodilator (hydralazine). J Trauma. 1971;11:36\u201346.","journal-title":"J Trauma"},{"key":"793_CR33","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1097\/00000658-199604000-00009","volume":"223","author":"JJ Kelemen","year":"1996","unstructured":"Kelemen JJ, Cioffi WG, Mason AD, Mozingo DW, McManus WF, Pruitt BA. Effect of ambient temperature on metabolic rate after thermal injury. Ann Surg. 1996;223:406\u201312.","journal-title":"Ann Surg"},{"key":"793_CR34","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.clnu.2006.01.021","volume":"25","author":"KG Kreymann","year":"2006","unstructured":"Kreymann KG, Berger MM, Deutz NEP, Hiesmayr M, Jolliet P, Kazandjiev G, et al. ESPEN guidelines on enteral nutrition: intensive care. Clin Nutr. 2006;25:210\u201323.","journal-title":"Clin Nutr"},{"key":"793_CR35","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","volume":"43","author":"A Rhodes","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis campaign: international guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017;43:304\u201377.","journal-title":"Intensive Care Med"},{"key":"793_CR36","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.annder.2011.05.029","volume":"138","author":"L Valeyrie-Allanore","year":"2011","unstructured":"Valeyrie-Allanore L, Ingen-Housz-Oro S, Colin A, Thuillot D, Sigal M-L, Binhas M. Pain management in Stevens-Johnson syndrome, toxic epidermal necrolysis and other blistering diseases. Ann Dermatol V\u00e9n\u00e9r\u00e9ologie. 2011;138:694\u20137. quiz 692-693, 698","journal-title":"Ann Dermatol V\u00e9n\u00e9r\u00e9ologie"},{"key":"793_CR37","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s001340050492","volume":"23","author":"F Lebargy","year":"1997","unstructured":"Lebargy F, Wolkenstein P, Gisselbrecht M, Lange F, Fleury-Feith J, Delclaux C, et al. Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study. Intensive Care Med. 1997;23:1237\u201344.","journal-title":"Intensive Care Med"},{"key":"793_CR38","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/PRS.0b013e3181773d5d","volume":"122","author":"AH Dorafshar","year":"2008","unstructured":"Dorafshar AH, Dickie SR, Cohn AB, Aycock JK, O\u2019Connor A, Tung A, et al. Antishear therapy for toxic epidermal necrolysis: an alternative treatment approach. Plast Reconstr Surg. 2008;122:154\u201360.","journal-title":"Plast Reconstr Surg"},{"key":"793_CR39","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.burns.2007.06.008","volume":"34","author":"P Boorboor","year":"2008","unstructured":"Boorboor P, Vogt PM, Bechara FG, Alkandari Q, Aust M, Gohritz A, et al. Toxic epidermal necrolysis: use of biobrane or skin coverage reduces pain, improves mobilisation and decreases infection in elderly patients. Burns. 2008;34:487\u201392.","journal-title":"Burns"},{"key":"793_CR40","first-page":"157","volume":"145","author":"J Gueudry","year":"2009","unstructured":"Gueudry J, Roujeau J-C, Binaghi M, Soubrane G, Muraine M. Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis. Arch Dermatol. 2009;145:157\u201362.","journal-title":"Arch Dermatol"},{"key":"793_CR41","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ajo.2010.04.026","volume":"150","author":"ME Morales","year":"2010","unstructured":"Morales ME, Purdue GF, Verity SM, Arnoldo BD, Blomquist PH. Ophthalmic manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis and relation to SCORTEN. Am J Ophthalmol. 2010;150:505\u2013510.e1.","journal-title":"Am J Ophthalmol"},{"key":"793_CR42","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jtos.2016.02.001","volume":"14","author":"S Kohanim","year":"2016","unstructured":"Kohanim S, Palioura S, Saeed HN, Akpek EK, Amescua G, Basu S, et al. Acute and chronic ophthalmic involvement in Stevens-Johnson syndrome\/toxic epidermal necrolysis - a comprehensive review and guide to therapy. II. Ophthalmic disease. Ocul Surf. 2016;14:168\u201388.","journal-title":"Ocul Surf"},{"key":"793_CR43","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1001\/jamadermatol.2014.4844","volume":"151","author":"E Bequignon","year":"2015","unstructured":"Bequignon E, Duong TA, Sbidian E, Valeyrie-Allanore L, Ingen-Housz-Oro S, Chatelin V, et al. Stevens-Johnson syndrome and toxic epidermal necrolysis: ear, nose, and throat description at acute stage and after remission. JAMA Dermatol. 2015;151:302\u20137.","journal-title":"JAMA Dermatol"},{"key":"793_CR44","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.annder.2016.09.680","volume":"144","author":"V Sobocinski","year":"2016","unstructured":"Sobocinski V, Dridi S-M, Bisson C, Jeanne S, Gaultier F, Prost-Squarcioni C, et al. Oral care recommendations for patients with oral autoimmune bullous diseases. Ann Dermatol Venereol. 2016;144:182\u201390.","journal-title":"Ann Dermatol Venereol"},{"key":"793_CR45","first-page":"81","volume":"4","author":"DJ Kaser","year":"2011","unstructured":"Kaser DJ, Reichman DE, Laufer MR. Prevention of vulvovaginal sequelae in stevens-Johnson syndrome and toxic epidermal necrolysis. Rev Obstet Gynecol. 2011;4:81\u20135.","journal-title":"Rev Obstet Gynecol"},{"key":"793_CR46","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1001\/jamadermatol.2016.5668","volume":"153","author":"S Zimmermann","year":"2017","unstructured":"Zimmermann S, Sekula P, Venhoff M, Motschall E, Knaus J, Schumacher M, et al. Systemic Immunomodulating therapies for Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. JAMA Dermatol. 2017;153:514\u201322.","journal-title":"JAMA Dermatol"},{"key":"793_CR47","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1177\/2042098611404094","volume":"2","author":"J-C Roujeau","year":"2011","unstructured":"Roujeau J-C, Bastuji-Garin S. Systematic review of treatments for Stevens-Johnson syndrome and toxic epidermal necrolysis using the SCORTEN score as a tool for evaluating mortality. Ther Adv Drug Saf. 2011;2:87\u201394.","journal-title":"Ther Adv Drug Saf"},{"key":"793_CR48","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jaip.2017.11.023","volume":"6","author":"KD White","year":"2018","unstructured":"White KD, Abe R, Ardern-Jones M, Beachkofsky T, Bouchard C, Carleton B, et al. SJS\/TEN 2017: building multidisciplinary networks to drive science and translation. J Allergy Clin Immunol Pract. 2018;6:38\u201369.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"793_CR49","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/archderm.139.1.33","volume":"139","author":"N Bachot","year":"2003","unstructured":"Bachot N, Revuz J, Roujeau J-C. Intravenous immunoglobulin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis: a prospective noncomparative study showing no benefit on mortality or progression. Arch Dermatol. 2003;139:33\u20136.","journal-title":"Arch Dermatol"},{"key":"793_CR50","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/j.1365-2133.2012.11074.x","volume":"167","author":"HY Lee","year":"2012","unstructured":"Lee HY, Dunant A, Sekula P, Mockenhaupt M, Wolkenstein P, Valeyrie-Allanore L, et al. The role of prior corticosteroid use on the clinical course of Stevens-Johnson syndrome and toxic epidermal necrolysis: a case-control analysis of patients selected from the multinational EuroSCAR and RegiSCAR studies. Br J Dermatol. 2012;167:555\u201362.","journal-title":"Br J Dermatol"},{"key":"793_CR51","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1111\/j.1365-2133.2010.09863.x","volume":"163","author":"L Valeyrie-Allanore","year":"2010","unstructured":"Valeyrie-Allanore L, Wolkenstein P, Brochard L, Ortonne N, Ma\u00eetre B, Revuz J, et al. Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol. 2010;163:847\u201353.","journal-title":"Br J Dermatol"},{"key":"793_CR52","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1016\/j.jid.2017.05.022","volume":"137","author":"C Gonz\u00e1lez-Herrada","year":"2017","unstructured":"Gonz\u00e1lez-Herrada C, Rodr\u00edguez-Mart\u00edn S, Cachafeiro L, Lerma V, Gonz\u00e1lez O, Lorente JA, et al. Cyclosporine use in epidermal necrolysis is associated with an important mortality reduction: evidence from three different approaches. J Invest Dermatol. 2017;137:2092\u2013100.","journal-title":"J Invest Dermatol"},{"key":"793_CR53","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jaad.2016.07.048","volume":"76","author":"HY Lee","year":"2017","unstructured":"Lee HY, Fook-Chong S, Koh HY, Thirumoorthy T, Pang SM. Cyclosporine treatment for Stevens-Johnson syndrome\/toxic epidermal necrolysis: retrospective analysis of a cohort treated in a specialized referral center. J Am Acad Dermatol. 2017;76:106\u201313.","journal-title":"J Am Acad Dermatol"},{"key":"793_CR54","doi-asserted-by":"publisher","unstructured":"Poizeau F, Gaudin O, Le Cleach L, Duong TA, Hua C, Hotz C, et al. Ciclosporin for epidermal necrolysis: absence of beneficial effect in a retrospective cohort of 174 patients - exposed\/unexposed and propensity-score matched analyses. J Invest Dermatol. 2018; \n                    https:\/\/doi.org\/10.1016\/j.jid.2017.12.034\n                    \n                  . [Epub ahead of print]","DOI":"10.1016\/j.jid.2017.12.034"},{"key":"793_CR55","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/S0140-6736(98)02197-7","volume":"352","author":"P Wolkenstein","year":"1998","unstructured":"Wolkenstein P, Latarjet J, Roujeau JC, Duguet C, Boudeau S, Vaillant L, et al. Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis. Lancet. 1998;352:1586\u20139.","journal-title":"Lancet"},{"key":"793_CR56","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/01.bcr.0000194268.01514.f8","volume":"27","author":"A Oplatek","year":"2006","unstructured":"Oplatek A, Brown K, Sen S, Halerz M, Supple K, Gamelli RL. Long-term follow-up of patients treated for toxic epidermal necrolysis. J Burn Care Res. 2006;27:26\u201333.","journal-title":"J Burn Care Res"},{"key":"793_CR57","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1159\/000358295","volume":"228","author":"A Isvy-Joubert","year":"2014","unstructured":"Isvy-Joubert A, Ingen-Housz-Oro S, Vincent R, Haddad C, Valeyrie-Allanore L, Chosidow O, et al. Severe cutaneous adverse reactions to drugs: from patients to the national office for compensation of medical accidents. Dermatology. 2014;228:338\u201343.","journal-title":"Dermatology"},{"key":"793_CR58","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000070938","volume":"207","author":"S Magina","year":"2003","unstructured":"Magina S, Lisboa C, Leal V, Palmares J, Mesquita-Guimar\u00e3es J. Dermatological and ophthalmological sequels in toxic epidermal necrolysis. Dermatology. 2003;207:33\u20136.","journal-title":"Dermatology"},{"key":"793_CR59","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1001\/archdermatol.2009.233","volume":"145","author":"F Gaultier","year":"2009","unstructured":"Gaultier F, Rochefort J, Landru M-M, Allanore L, Naveau A, Roujeau J-C, et al. Severe and unrecognized dental abnormalities after drug-induced epidermal necrolysis. Arch Dermatol. 2009;145:1332\u20133.","journal-title":"Arch Dermatol"},{"key":"793_CR60","first-page":"153","volume":"42","author":"E Meneux","year":"1997","unstructured":"Meneux E, Paniel BJ, Pouget F, Revuz J, Roujeau JC, Wolkenstein P. Vulvovaginal sequelae in toxic epidermal necrolysis. J Reprod Med. 1997;42:153\u20136.","journal-title":"J Reprod Med"},{"key":"793_CR61","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1111\/bjd.14799","volume":"175","author":"RP Dodiuk-Gad","year":"2016","unstructured":"Dodiuk-Gad RP, Olteanu C, Feinstein A, Hashimoto R, Alhusayen R, Whyte-Croasdaile S, et al. Major psychological complications and decreased health-related quality of life among survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol. 2016;175:422\u20134.","journal-title":"Br J Dermatol"},{"key":"793_CR62","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.ajo.2009.07.006","volume":"148","author":"B Tougeron-Brousseau","year":"2009","unstructured":"Tougeron-Brousseau B, Delcampe A, Gueudry J, Vera L, Doan S, Hoang-Xuan T, et al. Vision-related function after scleral lens fitting in ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis. Am J Ophthalmol. 2009;148:852\u2013859.e2.","journal-title":"Am J Ophthalmol"},{"key":"793_CR63","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1089\/jop.2012.0009","volume":"29","author":"P Prabhasawat","year":"2013","unstructured":"Prabhasawat P, Tesavibul N, Karnchanachetanee C, Kasemson S. Efficacy of cyclosporine 0.05% eye drops in Stevens Johnson syndrome with chronic dry eye. J Ocul Pharmacol Ther. 2013;29:372\u20137.","journal-title":"J Ocul Pharmacol Ther"},{"key":"793_CR64","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.survophthal.2009.03.004","volume":"54","author":"E Shay","year":"2009","unstructured":"Shay E, Kheirkhah A, Liang L, Sheha H, Gregory DG, Tseng SCG. Amniotic membrane transplantation as a new therapy for the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis. Surv Ophthalmol. 2009;54:686\u201396.","journal-title":"Surv Ophthalmol"},{"key":"793_CR65","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1034\/j.1600-0536.2001.450601.x","volume":"45","author":"A Barbaud","year":"2001","unstructured":"Barbaud A, Gon\u00e7alo M, Bruynzeel D, Bircher A, European Society of Contact Dermatitis. Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions. Contact Dermatitis. 2001;45:321\u20138.","journal-title":"Contact Dermatitis"},{"key":"793_CR66","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/bjd.12125","volume":"168","author":"A Barbaud","year":"2013","unstructured":"Barbaud A, Collet E, Milpied B, Assier H, Staumont D, Avenel-Audran M, et al. A multicentre study to determine the value and safety of drug patch tests for the three main classes of severe cutaneous adverse drug reactions. Br J Dermatol. 2013;168:555\u201362.","journal-title":"Br J Dermatol"},{"key":"793_CR67","doi-asserted-by":"publisher","first-page":"897","DOI":"10.2147\/TCRM.S131021","volume":"13","author":"N Brickel","year":"2017","unstructured":"Brickel N, Shaikh H, Kirkham A, Davies G, Chalker M, Yoshida P. Collaboration in pharmacovigilance: lamotrigine and fatal severe cutaneous adverse reactions - a review of spontaneous reports. Ther Clin Risk Manag. 2017;13:897\u2013903.","journal-title":"Ther Clin Risk Manag"},{"key":"793_CR68","first-page":"5","volume":"8","author":"P-D Ghislain","year":"2002","unstructured":"Ghislain P-D, Roujeau J-C. Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Dermatol Online J. 2002;8:5.","journal-title":"Dermatol Online J"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0793-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-018-0793-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0793-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T19:51:53Z","timestamp":1554839513000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-018-0793-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,10]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["793"],"URL":"https:\/\/doi.org\/10.1186\/s13023-018-0793-7","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,10]]},"assertion":[{"value":"2 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"56"}}